Moving on to greener pastures.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great information from Mazor
https://www.mazorrobotics.com/index.php/resources-for/media/press-releases/356-mazor-robotics-received-19-system-orders-during-q2-2017-expects-to-report-record-quarterly-revenue
Mazor Robotics Received 19 System Orders During Q2 2017; Expects to Report Record Quarterly Revenue
CAESAREA, Israel--(BUSINESS WIRE)-- Mazor Robotics Ltd. (TASE:MZOR; NASDAQGM:MZOR), a pioneer and a leader in the field of surgical guidance systems, expects to report record revenue of approximately $15.4 million for the second quarter ended June 30, 2017. In the year-ago second quarter, Mazor reported revenue of $8.3 million. During the second quarter of 2017, the Company received a total of 19 system purchase orders. Sixteen of the purchase orders were for the Mazor X™ system from customers in the U.S., including seven trade-in orders from customers who had previously purchased Renaissance® systems. In addition, the Company received purchase orders for three Renaissance systems, including two in the international market and one in the U.S. market.
“Our second quarter performance reflects the market's enthusiasm for the Mazor X system and demand continues to grow,” commented Ori Hadomi, Chief Executive Officer. “The sales momentum and the successful execution of our growth strategies, supported by ongoing product innovation and the recent leadership additions and organizational steps, position Mazor for sustainable growth.”
Mazor's system backlog at the end of the second quarter was 14 systems, similar to the first quarter ended March 31, 2017. The backlog was adjusted to reflect a Mazor X system that was ordered in a previous quarter and subsequently cancelled in the 2017 second quarter. The Company expects to deliver these systems in the second half of 2017. The Company intends to report its financial results for the second quarter ended June 30, 2017 on August 1, 2017 and will issue a press release with the specific time, dial-in credentials and webcast details.
About Mazor
Mazor Robotics (TASE: MZOR; NASDAQGM: MZOR) believes in healing through innovation by developing and introducing revolutionary technologies and products aimed at redefining the gold standard of quality care. Mazor Robotics Guidance Systems enable surgeons to conduct spine and brain procedures in an accurate and secure manner. For more information,
please visit HOME PAGE
Ernie just remember that Rite Aid had 30 Billion in sales in 2016. There will be an activist stepping in and I bet that Walgreens ends up with out their stores. The activist will work for a bigger or better sale or just run the dam company.
They will sell the PBM to Amazon as part up cleaning up the debt. Somebody will get it right.
An activist or Private Equity has been waiting for this moment to come in and fix Rite Aid. Too much opportunity there for making a big load of cash cleaning it up.
Good for you. I love my Intuitive investment. it allows me to sleep at night. Mazor is not a risky investment today. They have a legitimate product in the Mazor X and their other tools.
Look at this one for a risky company with some upside CVRS which is a heart stent surgical company.
Also a start up Israel company CHEK. Israeli companies like Mazor always delivers on Great products and PPS long term.
The key is the future opportunity. Its ugly today. But somebody at this cheap price will make an unsolicited offer and buy into or buy the entire company. They can break it up and make money.
Private equity knows how to get the job done. They could buy it and sell the PBM to Amazon or perhaps Amazon will make a bid. Perhaps not.
At 2.39 a share a activist can buy 20% interest cheaply and force the board to seat members of his team on it. The can then deal with getting management who will turn the company around. It has happened many times over the last 20 years. Most recently Jana Partners did it to Whole Foods.
Look what happened there in less than 90 days of their pushing their way onto the board. The company was sold.
This will be the big deal of 2017 in the Pharma space.
Rad can't solicit any offers for 60 days but if an unsolicited offer comes in during that time they will have to deal with it.
What will happen I don't know. But I will hold on for the wild ride. No reason to sell it until 12/31/2017 if I'm wrong.
Pay attention and realize the PERFECT STORM is upon us. Somebody in Private Equity will take the leap and chance to get a 10 bagger.
Keep your eye on this site. You can sometimes spot who is about ready to pounce.
https://fintel.io/activists
What is an Activist Investor?
Every investor that acquires 5% of a company is required to file a beneficial ownership filing, which is either a Form 13D or Form 13G, within ten (10) days of the event. If the investor intends to influence management, then they are considered an activist investor and must file a 13D. Carl Icahn is a well-known activist investor. If they do not intend to influence management, then they are considered a passive investor and must file a 13G. Vanguard, because of it's size, owns more than 5% of many companies. Since it is a passively managed fund, it files Forms 13G. If there is any change in the ownership, investors must make amendments to their original filings, with either forms 13D/A, or 13G/A. If a passive investor that has filed a 13G decides they want to influence management, they must file a new 13D that supercedes their original 13G.
There is evidence that suggests investing alongside activist investors is a stock market investing strategy that can produce excess returns. This free screener shows all of the required Schedule 13D filings made by activist investors.
Investor Groups
Additionally, filers of 13Ds often organize investor groups in order to have more leverage when influencing management. Fintel only identifies the lead investor of an investor group. To see the other members of the group, read the original filing by clicking on the form type in the Form column. You cannot directly compare shares reported in a 13D/G with shares reported by the investor in a 13F, since the 13D/G filings may include other investors.
I saw one of these in New York City. That is a positive trend
Some trends are very deceiving but easy to spot.
It's easy to spot the negative trends.
But you have to wait for the positive trend upwards to begin. Weekly script numbers, positive comments on social media.
Eventually the trend becomes very positive on Afrezza.
Especially for a Private Equity fund who will make it a 10 bagger in 12 to 18 months or less
Does the 60 day Gag order prevent any unsolicited bids or offers. Can you post s link to the exact verbiage posted on that 60 day period.
Was this in the Walgreens release or the Rite Aid release or both.
Can you imagine a private equity fund buying on the open market 200 million shares or 20% of the company for $500 million.
That private equity fund would force the board to take immediate action to clean up their act. And get shareholder value.
This is not my fantasy. But perhaps a reality as they know how to grind the sausage of Wall Street arbitrage and make big dollars.
The lower the stock price goes the easier it will be for somebody to step forward and say by golly I'm going to Buy in to the company and force the board to make the changes they should have years ago.
A private equity company or investor does not have to disclose publicly how many shares they have until after they hit the 5% threshold. I believe they have 10 days after that point to report. So they're very well may be some news coming before the July shareholders meeting.
While the activist would not be able to vote their shares at that meeting. They could make enough noise and tell them to give them a couple of board positions immediately.
This scenario has happened many times at public companies over the last 20 years.
Based on the closing price today I would assume we will see shortly some activist investor make a buy into the company. That activist will then request a board seat.
The activist will know how to get the best value out of the company just like JANA Partners did with whole foods last month.
There are many private equity funds which would make a play to take over Rite aid.
Are they paying attention to what is currently happening? You bet they are and can believe that they will buy shares while it's cheap.
They do not have to disclose position until after they have purchased 5% of the outstanding shares. They can do that very cheaply right now
At today's closing price you can bet somebody could accumulate 15% or 20% since last week's announcement. They have 10 days to disclose their position to the SEC.
The cheap share price is like a ticking bomb it will go off SHORTLY.
Nice run today. Look forward to the next 12 to 18 months with Mazor.
Reminds me of intuitive which I have been invested in since 2010
Like what I am seeing not sure why we were moving upwards.
Martin I think we both see a positive trend that we ignore some drivel. Time will be on our side as this company sales will trend upwards
Great article in Barron's this week seem this company is a hidden gem for replacement parts.
Hypi, I guess we see why the trend is is always seems to be a negative one with the same viewpoints being stated over and over again like Spencer.
Why do people like him or wild pig or some of the others keep spewing the negative trend. They have a agenda to see the product fail and the company go out of existence.
Negative trends will eventually be reversed. It's just a matter of time.
Afrezza is a superior product to liquid insulin. We will see sales improve which will be a very positive trend.
Stay tuned.
Horrible deal if that happens. We might even see $9.00 from the transaction.
Whether it's Amazon that buys the company or Apollo global management, KKR, Cererbus or the many other companies that make a market in buying distressed businesses there will be a deal perhaps before they can partial off the stores to Walgreens.
Look at what JANA Partners did when they got involved with Whole Foods Markets in March 2017. They knew what to do and they accomplished their plan very quickly.
There is a deal to be made in the near future and hopefully it will prove to be very good for the shareholders of Rite Aid.
I am very long and looking at buying more shares. I think everything will be A-OK
If not Walgreens because the FTC denies the merger. Then you have to look towards another buyer like Amazon. If Amazon is not interested the third wire maybe a private equity firm like Apollo global management who today in the New York Times deal book section in the kid they have $23.5 billion available to invest in deals to acquire companies.
$RAD if not $WBA or $AMZN ?
Apollo’s Huge Buyout firm 23.5 billion buyout Fund Provides for a Large Margin of Error
https://nyti.ms/2ujBPQC?
Just think with 23 .5 billion to do buyouts With no problem raising capital who could The next target P if Walgreens is not successful in buying Rite Aid.
https://www.nytimes.com/2017/06/28/business/dealbook/apollo-global-management-buyout-fund.html?ref=dealbook&referer=http://www.nytimes.com/pages/business/dealbook/index.html?nytmobile=0&nytmobile=0
What is your Canadian gem? Not titan?
The deal is on and if it does not occur this is what will ultimately happen. Maybe with Amazon or somebody else.
$RAD $SPLS you see there is life after a turned down merger by the FTC. Good for Staples
Rite Aid 4600 Stores + PBM + 30.9 billion in Sales.
Staples 1500 Stores and 18.2 Billion in sales.
SOMEBODY WILL WANT TO BUY RITE AID.... PRIVATE EQUITY OR AMAZON.
http://www.marketwatch.com/story/staples-close-to-65-billion-sale-to-sycamore-2017-06-28
Staples close to $6.5 billion sale to Sycamore
Private-equity firm Sycamore Partners is nearing a deal to buy the office-supply retailer Staples Inc. for more than $6.5 billion, a bold bet on a company whose sales have been shrinking in recent years.
Sycamore is expected to pay more than $10 per share for Staples in a deal that could be announced as soon as Wednesday, according to people familiar with the matter.
The exact price couldn't be learned.
A price of more than $10 a share would be a premium to the $9.22 that the retailer's shares traded at on Wednesday afternoon.
In early April, just before The Wall Street Journal reported that Staples was exploring a sale, the shares were trading at around $8.66.
The deal would be the biggest leveraged buyout this year. It comes at a time of turmoil for retailers of all stripes as consumers increasingly shop online. It would value Staples at a deep discount to where the company was trading just a few years ago -- and to its annual revenue, which came in at $18.2 billion in the fiscal year ended in January
Looks like the street is vacillating back-and-forth and adding a whole wall of new players to what could be a wild couple of weeks.
https://www.thestreet.com/story/14198552/1/amazon-could-easily-own-whole-foods-rite-aid-and-express-scripts-this-top-analyst-says.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo
Love to see a copy of that because I'm currently at this minute on the
Merrill Lynch website and they do not make any comments about it.
Equity
In fact their narrative says the following:
Page 2 of 12
Company description:
We have removed the investment opinion on the company's stock, just you should know longer rely on our previous opinion or price objective.
Investment rationale:
We have removed the investment opinion on the company's stock. Investors should longer relying on our previous opinion or price objective.
B of A. Merrill did not say that Here is what the say as of today from their 12 page Equity report.
Rite Aid / The Decision
This is what they said as of June 27th, 2017
What to expect with imminent FTC merger decision:
After a series of conflicting broad news reports in recent months regarding the proposed Walgreens/Rite Aid merger, shares of RAD were up over 30% on Monday after trading downward for most of CY17 thus far (but still down -50% YTD after Monday’s move). Broad news articles this week now suggest that the FTC has scheduled a closed- door meeting for Thurs June 29, and that the FTC may reach a merger decision this week, slightly ahead of the July 7 deadline imposed by WBA’s ‘certified compliance.’ News articles yesterday also suggested that anti-trust officials and a former high- ranking DOJ official are suggesting that merger approval is “more likely than not.” Given the whipsaw occurring in broad news reports related to this proposed merger over the past 20 mths, we continue to view news articles as less dependable to predict FTC vote. But we do provide in this note thoughts on RAD valuation heading into the FTC vote.
RAD shares may continue to be volatile over next 2 wks:
Given varying levels of debt at CVS/WBA/RAD, we believe it is appropriate to compare valuations of the companies using EV/EBITDA metrics. RAD is currently posting double- digit y-o-y declines in EBITDA. It is difficult to determine how much is due to M&A overhang vs. true fundamental trends that would have occurred ex-M&A overhang, but nevertheless trends are inferior to WBA and CVS. Further, RAD’s ratio of operating cash flow (OCF)-to-EBITDA and FCF-to-EBITDA are inferior to peers (see pg 3). For these reasons, RAD traded at an EV/EBITDA discount to CVS and WBA prior to the merger announcement of WBA/RAD, and may still trade at a discount post-merger as well. CVS currently trades at 7.7x EV/EBITDA on our CY18, while WBA trades at 8.2x our CY18 EBITDA. RAD shares would start to trade at a discount to peers at ~$1.50 (=7.5x EBITDA on our CY18 estimates). Another variable is whether WBA would try to litigate with FTC to still pursue the RAD merger. We note the break-up fee from WBA to RAD would be $325 mln if WBA walks away in this scenario. Separately, at the current ~$4 stock price for RAD, the current EV/EBITDA multiple is 10x. At the proposed takeout price of $6.50- 7.00 per share (varies based on store divestiture requirement), RAD valuation equals 12.5x CY18 EV/EBITDA.
Special Disclosure statement:
BofA Merrill Lynch is currently acting as a financial advisor to Walgreens Boots Alliance Inc in connection with Walgreens Boots Alliance Inc and Rite Aid Corp's proposed sale of 865 stores and certain assets related to store operations to Fred's Inc, which was announced on December 20, 2016.
Have to agree with you. Whether or not we get FTC approval. Something good is going to happen shortly.
The landscape has changed quite a bit in retail in the last 20 months since it still came about.
There is no secret that Amazon wants in the pharmacy business.
They have started rolling out their Amazon go concept.
Amazon go would fit nicely into existing Rite Aid stores.
Amazon is not conflicted with antitrust issues in the pharmacy space like Walgreens.
Amazon can keep all the Rite Aid stores. No divestiture needed .
There are millions of customers currently of customers
At Rite aid filling prescriptions.
Many of these customers are already Amazon customers.
Amazon can wait until after the FTC makes a decision and then they can make an offer. Will they make an offer? Nobody knows. But Amazon.
But if they do make an offer right aid is able to except it if it's a better deal.
So if they offered $9.00 a share game on. There is a clause in the current agreement with Walgreens known as the no shop provision. It states the terms that a second offer can be made.
See the information below:
No-shop provision and breakup fees
RAD has a no-shop provision with a “fiduciary out,” which means that it cannot talk to other potential purchasers while the transaction is pending. However, the “fiduciary out” does allow RAD to talk to a bidder who makes an unsolicited approach if the Board of Directors believes such talks can lead to a bona fide superior offer.
If Rite Aid accepts a superior bid, it will owe Walgreens a termination fee of $325 million. If Walgreens cannot obtain regulatory approval, it will owe Rite Aid a reverse termination fee of $325 million. This reverse termination fee can increase to $650 million under certain circumstances.
I like looking at big blocks on most stock over 10,000 shares.
But on RAD you have to look at 50,000 shares or more as there are way too many of them being traded.
I guess the HFT boys play this all day for quarters and that amounts to big dollars with the wild swings that a stock like RAD has every day.
Block trades over 10,000 shares were 949 for a total of 19,995,389 shares.
There are some big WHALE blocks of shares that moved today. this shows blocks over 90,0000 shares.
lots of movement and action. Is this good or bad? Hell I don't know since I'm a dumb retail shareholder.
I do know its worth sticking around as whether or not the FTC approves. Something good will happen for shareholders of Rite Aid.
my preference is to see it approved by the FTC and then have a better offer come in from perhaps Amazon with an offer for the whole deal as outlined in October 2015 for $9.00
Perhaps that is a fantasy but this is wall street and big stakes for the Pharma industry for leadership in scale and scope for the future.
---------------------------------------
No-shop provision and breakup fees
RAD has a no-shop provision with a “fiduciary out,” which means that it cannot talk to other potential purchasers while the transaction is pending. However, the “fiduciary out” does allow RAD to talk to a bidder who makes an unsolicited approach if the Board of Directors believes such talks can lead to a bona fide superior offer.
If Rite Aid accepts a superior bid, it will owe Walgreens a termination fee of $325 million. If Walgreens cannot obtain regulatory approval, it will owe Rite Aid a reverse termination fee of $325 million. This reverse termination fee can increase to $650 million under certain circumstances.
The ultimate dagger is that the FTC approves the deal with getting rid of 1200 stores and Amazon steps up and offers the original October 2015 deal of $9.00 per shares with Closing by the end of 2017 since Regulators can't block this space that Amazon is not in yet.
Amazon gets Rite Aid for a good value with 1200 more stores that Walgreens could kept because of the FTC. They get the Mail order PBM which is the Jewel of the transaction.
Do you think that the inept Rite Aid management and Board would not like to stick it to the FTC and Walgreens for making this a prolonged abyss
Great Segment on KTLA TV in LA. With Damon Dash and how MannKind's Afrezza has changed his life.
$MNKD Great segment on #KTLA tv with #damondash how he likes and uses #afrezza to treat his #T1D #diabetes #PWD
http://ktla.com/2017/06/26/music-mogul-damon-dash-on-new-treatment-option-for-type-1-diabetes-the-dash-diabetes-network/amp/
Comcast , Chart and sprint are chatting about a deal. T-Mobile talks suspended for 60 Days.
http://www.cnbc.com/2017/06/26/sprint-reportedly-in-exclusive-talks-with-charter-comcast-in-bid-to-offer-wireless-service.html
Crazy things could happen but doubtful. You have to wonder what would happen if the FDA approved the sale on Thursday and on Friday Rite Aid gets an unsolicited offer from Amazon. The would be able to use the
"FIDUCIARY OUT"clause if they accepted the higher offer. Not that a higher offer would occur but the whole deal has been crazy. Amazon steps up and offers Rite Aid a deal that Walgreens couldn't match due to FTC requirement to sell 1200 stores.
Read below:
No-shop provision and breakup fees
RAD has a no-shop provision with a “fiduciary out,” which means that it cannot talk to other potential purchasers while the transaction is pending. However, the “fiduciary out” does allow RAD to talk to a bidder who makes an unsolicited approach if the Board of Directors believes such talks can lead to a bona fide superior offer.
If Rite Aid accepts a superior bid, it will owe Walgreens a termination fee of $325 million. If Walgreens cannot obtain regulatory approval, it will owe Rite Aid a reverse termination fee of $325 million. This reverse termination fee can increase to $650 million under certain circumstances.
http://marketrealist.com/2015/11/rite-aid-walgreens-merger-walgreens-moves-rival-cvs/
If it gets blocked by the FTC then
Bring on the next player. Will it be Amazon? Could be or Apollo Global Management,, Cerberus Capital Management or KKR.
There is blood in the water and somebody else with more money and no reason to sell off 1200 stores will buy Rite Aid.
Stay Tuned. It should be exciting.
Forbes article earlier this month.
If Walgreens Can't Close Rite Aid Deal, Amazon Has An Opening
https://www.forbes.com/forbes/welcome/?toURL=https://www.forbes.com/sites/brucejapsen/2017/06/20/if-walgreens-cant-close-rite-aid-amazon-has-an-opening/&refURL=&referrer=#21b740987d44
Amazon is not conflicted as they are not in the business today. If they really want into the Pharmacy business and the PBM business then an all cash deal would be easy for them to pull off.
What can the FTC say? Nothing since they are not in that space. If the didn't want to buy for cash then they could do a stock deal. As a stock deal it does not even amount to a pimple to Amazon. I would gladly trade my shares of Rite aid for shares in Amazon.
Rite Aid value to Amazon is more than today's WBA value. Amazon could pay $10.00 and make the deal happen since sales already exist and today's sales would provide the cash flow immediately.
Rite Aid stores could be an easy way to expand the Amazon GO Footprint especially the urban stores.
Don't discount that there are not other suitors waiting for the FTC to deny the Walgreens buyout.
Rite Aid stores would be a good set up for Amazon Go concept.
Now Amazon needs to focus on Pharma. If the FTC denies the Walgreens/Rite Aid purchase I would look for Amazon to strike pretty fast within six months (or Sooner perhaps within 30 days).
Rite Aid would be a great addition to this concept of lite bricks and mortar. While the ultimate goal for Amazon is not to be in the real estate business you have to be there to be in the Pharma business as people need prescriptions immediately in 50% of the prescription orders. The rest of them can be satisfied by mail order. Amazon ones in the PBM business because there are hundreds of millions of dollars available to service.
Purchasing Rite Aid makes great sense when you consider that they all ready service millions of Americans on a daily basis. These are instant cash paying customers who can help them build the largest pharmacy network in the world.
So paying $10 a share for a ride aid would be a bargain entry point for Amazon.
For that investment they get a open running PBM and cash flow from the retail stores. They would not have to divest any locations since there would be no conflict of interest for the FTC to get upset about.
Again AMAZON would play the disrupter like they have to the grocery market with whole foods. Walgreens, CVS Caremark, Wal-Mart, would be behind the eight ball with an Amazon pharmacy entry by purchasing Rite Aid.
I am long Rite aid and personally would love to see the deal with Walgreens get denied by the federal trade commission since it would open the door for Amazon to swoop in and buy the company.
I believe that Amazon is going to take over the world and Jeff Bezos can't be denied at this time. He knows the right timing to make deals.
I could accept a $10.50 buy out but it seems its going to be a stock exchange.
Sometimes it's hard to follow the trend ??
I would wait for the price you indicated it would be.
Re: Ultimate Warrior Post# 3860
RAD will be a falling knife to .50
You know that Walgreens, Walmart and CVS do not look forward to Amazon entering the business.
FTC makes Walgreens sell 1200 stores. That is not a good deal.
FTC would not allow CVS to buy Rite Aid. Already too many stores.
FTC would not all Walmart to buy Rite Aid they have too much market share.
But FTC can't stop Amazon from buying since they are not in that business yet. YET is the key word.
The other big boys will whine and cry about Amazon entering the Pharma business but there is not much they can do to stop it.
This will be a positive Trend if it happens.
People still need to go and pick up prescriptions at the pharmacy. They can do Maintenance medicines by mail order PBM but if you need the med today or right away then you will go to the Local pharmacy.
The Amazon Go concept is ideal to fit inside of the current Rite Aid store. Don't think that Walgreens is not liking that Ideal. Go to NYC or Chicago and imagine if there were a lot of Amazon Go markets.
Pick up your Amazon order from a Amazon locker in the Rite Aid store.
For the record I am very long in RAD. I have 19,000 shares. So if the WBA deal happens great for me. If the FTC denies the deal then I am not going to worry about it as Rite Aid is ripe for the picking.
Follow the Positive Trend on Rite Aid. It will play out very SHORTLY.
Thinking next week we will see 36.00 again.
Great movement last week with no news. Who might be stalking Corindus. They don't have a lot of sales or installations yet.
Especially if the FTC Blocks Walgreens buyout. Then I would bet that Amazon would be in the wings waiting to buy it cheaply.